Effectiveness and safety of daclatasvir/sofosbuvir with or without ribavirin in genotype 3 hepatitis c virus infected patients. Results in real clinical practice

1. Margusino-Framiñán, L.
2. Cid-Silva, P.
3. Mena-Decea, Á.
4. Rodríguez-Osorio, I.
5. Pernas-Souto, B.
6. Delgado-Blanco, M.
7. Pertega-Díaz, S.
8. Martín-Herranz, I.
9. Castro-Iglesias, Á.